Ilant Health Extends Seed Round to $5.5 Million

NEW YORK — Ilant Health, a provider of obesity management and cardiometabolic health solutions, announced the extension of its seed round of fundraising from $3 million to $5.5 million. The women-led startup received additional funds from a combination of new health-oriented investors, including funds from LifeX Ventures, Celtic House Asia Partners, and Cornucopian Capital, as well as existing investors reaffirming their commitment to Ilant Health’s transformative mission.

The decision to extend the seed round comes on the heels of Ilant’s accelerating traction due to its robust clinical model and proprietary analytics. Notably, Ilant Health has garnered significant recognition, winning all three World 50 Group Academies — EHIR, HPIR, and PHIR, — and being selected for Highmark and Allegheny Health Network’s accelerator, AlphaLab Health. The company recently won the Employee Health Innovation Roundtable (EHIR) Traction Award, which recognizes the company garnering the greatest level of interest from EHIR employer members.

“AlphaLab Health looks for companies to solve problems facing healthcare today,” said Dr. Jeffrey Cohen, Chief Physician Executive at Allegheny Health Network. “Obesity is a major healthcare problem without an organized market approach to solving it. Ilant’s team incorporated behavioral modification, medical and surgical therapies into an organized approach utilizing their proprietary algorithm to tailor the best answer for each patient. We believe they will have a bright future helping provider and payor systems solve this critical healthcare need.”

As Ilant Health continues to gain widespread attention for its innovative value-based approach, it owes much of its success to the women who played pivotal roles in its success. Elina Onitskanky, CEO of Ilant Health, founded the company knowing that the gender gap in venture capital funding meant only 2% of funding goes toward women founders. However, Ilant has benefited from the steadfast support of healthcare leaders and other women leaders and investors, who helped shape the company into where it is today.